Dermaprazole Cream for Radiation Dermatitis in Head and Neck Cancer
Completed · Phase 2
Conditions studied: Cancer of the Head and Neck
In brief
In this study, the study team seek to conduct a pilot clinical study to evaluate the safety and efficacy of a reformulated proton pump inhibitor (PPI) cream (Dermaprazole) in definitive head and neck cancer (HNC) patients.
Key facts
- Study ID
- NCT04865731
- Run by
- The University of Texas Health Science Center at San Antonio
- People needed
- 6
- Starts
- 2022-06-15
- Expected to finish
- 2024-06-18
- Last updated by the study team
- 2025-08-06
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients with head and neck malignancy (including radiation therapy to primary head cancers of any histology and/or neck lymphatics, excluding brain malignancies)
- Biopsy proven diagnosis of head and neck malignancy
- Planned to receive definitive chemoradiation of at least 66Gy
- Age 18 years or older
- Eastern Cooperative Oncology Group (ECOG) performance status 0 - 2
- Written Informed Consent
- History and Physical within 12 weeks of enrollment
You may not qualify if…
- Prior head and neck radiotherapy
- Neoadjuvant chemotherapy
- Any serious medical condition or illness that would preclude the safe administration of the trial treatment including, but not limited to, active infection, symptomatic heart failure, unstable angina, psychiatric illness or social situations that would limit compliance with treatment
- Currently taking proton pump inhibitors. Eligible if discontinues with physician approval.
- Lack of concurrent chemotherapy
- Open wound at time of simulation
- Known autoimmune, connective tissue, or skin disorder; or other theoretical radiosensitivity to include bullous pemphigoid, dermatomyositis, lupus of the skin and scleroderma
Where it is running
- Mays Cancer Center — San Antonio, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.